Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Clinical Genetics

Understanding MLS Syndrome

At a Glance

MLS syndrome is a rare X-linked developmental condition, usually affecting girls, that mainly involves the eyes and skin. HCCS-related mitochondrial problems and X-chromosome inactivation help explain why features and severity differ widely between children.

Learning that your child has an ultra-rare condition like MLS syndrome can feel overwhelming and isolating. Because this diagnosis is so rare, you may find that your local doctors have never seen a case before. This is a common experience for families in the rare disease community [1]. It does not mean your child cannot receive excellent care; it simply means your medical team will likely need to consult with specialists at major academic or rare-disease centers who can provide guidance based on the latest research [2][3].

What is MLS Syndrome?

Microphthalmia with Linear Skin Defects (MLS) syndrome, also known as MIDAS syndrome, is a rare developmental condition that primarily affects the eyes and the skin [3][4]. The name itself is a medical description of its most common features:

  • Microphthalmia: One or both eyes are smaller than average from birth [4].
  • Linear Skin Defects: Red, streak-like areas of missing skin (dermal aplasia) that typically appear on the face and neck. These often heal into thin scars as a child grows [4][5].
  • MIDAS: This is an acronym for Microphthalmia, Dermal Aplasia, and Sclerocornea (clouding of the clear front part of the eye) [3][1].

While these are the core features, MLS is a “multisystem” condition. This means it can also involve the heart, the brain, or how a child grows and develops [3][2]. However, because the condition varies so much from person to person, your child’s experience will be unique to them [6][4].

Why Does It Affect Females Most?

Classic MLS is an X-linked dominant condition with male lethality [3][2]. To understand what this means, it helps to look at our chromosomes:

  • Females typically have two X chromosomes (XX).
  • Males typically have one X chromosome and one Y chromosome (XY).

In MLS, there is a genetic change (mutation) on one of the X chromosomes. Because males have only one X chromosome, severe loss of function in these genes is typically male-lethal, which is why the condition is almost exclusively seen in females [3][2]. On rare occasions, a male may be born with MLS or an overlapping condition if the genetic change is milder, if it only affects some of the cells in his body (mosaicism), or in other sex-chromosome contexts [2][7].

The Role of X-Chromosome Inactivation

You may wonder why one girl with MLS might have significant vision challenges while another has only mild skin findings. This is largely due to a natural process called X-chromosome inactivation [3][6].

In every female cell, one of the two X chromosomes is randomly “turned off.” If more cells happen to turn off the X chromosome with the mutation, the symptoms may be milder. If more cells turn off the “healthy” X chromosome, the symptoms may be more significant [6][8]. This process is largely random, tissue-specific (meaning it can be different in the skin versus the eyes), and happens early in development, which is why the severity of MLS is so unpredictable and varies enormously even between family members [3][8].

How the Mitochondria are Involved

The fundamental cause of MLS involves the mitochondria, which produce energy for the cell [3][7]. They take the food we eat and turn it into energy through a process called the mitochondrial respiratory chain [2].

Classic MLS is most strongly associated with pathogenic variants in the HCCS gene or Xp22.2 deletions encompassing HCCS [2]. Variants in other genes, such as COX7B or NDUFB11, can be associated with overlapping or MLS-like phenotypes, and their associated risks are not identical [2][7].

  • Energy Production: These genes help build the machinery that makes energy. When they don’t work correctly, the cell cannot produce enough power to develop certain tissues properly, especially the eyes and skin during pregnancy [3][2].
  • Cell Survival: These genes also play a role in telling cells when to stay alive and when to recycle themselves. If the mitochondria are struggling, some cells may die off earlier than they should during development [1].

An Ultra-Rare Reality

MLS is considered an ultra-rare disease. While there is no exact number of how many people have it worldwide, medical literature contains only a limited number of reported cases [4][7].

Because it is so rare, you should not expect your child to follow a “typical” path. Some children may have neurological or heart-related symptoms, while others do not [4][9]. Your child’s care team—led by a clinical geneticist—will help you monitor the specific areas where your child needs support, such as working with a pediatric ophthalmologist for eye care or a dermatologist for skin healing [4][3].

Finding a community of other families may take time, but connecting with larger rare-disease or mitochondrial-disorder organizations can provide a sense of belonging and support as you navigate this journey [1][2].

Glossary of Key Terms

  • HCCS / COX7B / NDUFB11: Genes involved in mitochondrial energy production linked to MLS and overlapping conditions.
  • Dermal Aplasia: Areas of missing or improperly formed skin.
  • Sclerocornea: Clouding or whitening of the cornea.
  • Xp22.2: The specific region on the X chromosome where the HCCS gene is located.
  • Mosaicism: Having a mix of cells in the body—some with the genetic variant, and some without.
  • IOP: Intraocular pressure (the fluid pressure inside the eye).
  • EUA: Examination Under Anesthesia, sometimes used to accurately assess pediatric eyes.
  • ECG: Electrocardiogram, a test that records the electrical activity and rhythm of the heart.
  • Echocardiogram: An ultrasound test that looks at the physical structure and pumping action of the heart.

Common questions in this guide

What is MLS syndrome?
MLS syndrome is a rare genetic developmental condition that mainly affects the eyes and skin. Common features include a small eye or eyes, linear areas of missing skin, and clouding of the cornea, but some children also have heart, brain, growth, or developmental concerns.
Why does MLS syndrome mostly affect girls?
MLS syndrome is usually linked to a change on the X chromosome. Because males typically have only one X chromosome, severe changes affecting the condition are often lethal before birth, while females may have a second X chromosome that changes how strongly the condition appears. Rare males can be affected in situations such as mosaicism or a milder genetic change.
What causes MLS syndrome?
Classic MLS syndrome is most strongly associated with a harmful change in the HCCS gene or a deletion in the Xp22.2 region that includes HCCS. These changes can disrupt mitochondrial energy production during development. Changes in COX7B or NDUFB11 may cause overlapping MLS-like conditions with different associated risks.
Why can MLS syndrome be mild in one child and more severe in another?
Differences in X-chromosome inactivation help explain the wide range of features. In each female cell, one X chromosome is naturally turned off, and the proportion of cells using one chromosome or the other can differ between tissues such as the eyes and skin. This process occurs early in development and is largely unpredictable.
Which specialists may care for a child with MLS syndrome?
A clinical geneticist can help coordinate evaluation and long-term care. Depending on the child’s findings, care may include a pediatric ophthalmologist for the eyes, a dermatologist for the skin, and cardiology or neurology specialists for heart or neurological concerns. A regional genetics or rare-disease center may also provide guidance.
Can MLS syndrome be inherited, or does it happen as a new genetic change?
A child’s genetic change may be inherited or may arise as a new change, and genetic testing can help clarify which occurred. A clinical geneticist or genetic counselor can explain what the result means for the child and the chance of the condition occurring again in the family.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child have a change in the HCCS, COX7B, or NDUFB11 gene, or a larger deletion on the X chromosome?
  2. 2.How does my child's specific genetic result or mosaicism levels relate to what we are seeing in their eyes, skin, or other organs?
  3. 3.Based on my child's unique findings, which specialists (like ophthalmologists, cardiologists, or neurologists) should we see for a baseline evaluation?
  4. 4.Is my child's genetic change 'de novo' (new to them) or was it inherited, and what does this mean for our family's future?
  5. 5.Since this condition is so rare, can you help coordinate our care with a regional genetics or rare-disease center?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Microphthalmia, Linear Skin Defects, Callosal Agenesis, and Cleft Palate in a Patient with Deletion at Xp22.3p22.2.

    Vendramini-Pittoli S, Candido-Souza RM, Quiezi RG, et al.

    Journal of pediatric genetics 2020; (9(4)):258-262 doi:10.1055/s-0039-3402047.

    PMID: 32765930
  2. 2

    Linear Skin Defects with Multiple Congenital Anomalies (LSDMCA): An Unconventional Mitochondrial Disorder.

    Indrieri A, Franco B

    Genes 2021; (12(2)) doi:10.3390/genes12020263.

    PMID: 33670341
  3. 3

    Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome.

    van Rahden VA, Fernandez-Vizarra E, Alawi M, et al.

    American journal of human genetics 2015; (96(4)):640-50.

    PMID: 25772934
  4. 4

    Variable phenotype of secondary congenital corneal opacities associated with microphthalmia with linear skin defects syndrome.

    Franco E, Scanga HL, Nischal KK

    American journal of medical genetics. Part A 2023; (191(2)):586-591 doi:10.1002/ajmg.a.63043.

    PMID: 36369709
  5. 5

    Microphthalmia and linear skin defects syndrome: Precise diagnosis guides prognosis.

    Satcher KG, Maegawa GHB, Schoch JJ

    Pediatric dermatology 2020; (37(1)):217-218 doi:10.1111/pde.13946.

    PMID: 31373408
  6. 6

    Novel Intragenic and Genomic Variants Highlight the Phenotypic Variability in HCCS-Related Disease.

    Reis LM, Basel D, Bitoun P, et al.

    Genes 2024; (15(12)) doi:10.3390/genes15121636.

    PMID: 39766903
  7. 7

    Revisiting LSDMCA: male lethality escape and genotype-phenotype correlations.

    D'Alessio AM, Indrieri A, Vitiello G, et al.

    European journal of human genetics : EJHG 2026; (34(7)):972-979 doi:10.1038/s41431-026-02098-7.

    PMID: 42014911
  8. 8

    A mosaic form of microphthalmia with linear skin defects.

    Prepeluh N, Korpar B, Zagorac A, et al.

    BMC pediatrics 2018; (18(1)):254 doi:10.1186/s12887-018-1234-4.

    PMID: 30068298
  9. 9

    Microphthalmia, Dermal Aplasia, and Sclerocornea Syndrome: Endoscopic Cyclophotocoagulation in the Management of Congenital Glaucoma.

    Thompson AC, Thompson MO, Lim ME, et al.

    Journal of glaucoma 2018; (27(1)):e7-e10 doi:10.1097/IJG.0000000000000812.

    PMID: 29088057

This page is for informational purposes only and does not constitute medical advice about MLS syndrome. Your child’s clinical geneticist and specialists should interpret genetic results and recommend care for your child’s individual needs.

Get notified when new evidence is published on Microphthalmia with linear skin defects syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.